Principal Investigators

Dr. Timothy Chuter is a vascular surgeon with a special interest in the use of branched and fenestrated stent-grafts to treat aneurysms of the aorta. Chuter designed, made and used the first bifurcated stent-graft for abdominal aortic aneurysm (AAA) repair, the first modular system for endovascular repair of an aortic arch aneurysm and the first modular system for bilateral iliac aneurysms.

Dr. Michael Conte is a vascular surgeon with a special interest in molecular based therapies to treat peripheral artery disease (PAD). His translational research program includes basic laboratory investigations as well as prospective clinical trials to study the causes of failure of angioplasty and bypass surgery and develop new approaches to stratify patients at risk.

Dr. Jade Hiramoto is a vascular surgeon with expertise in both clinical and translational research, with a special interest in the abnormal inflammatory response and kidney injury after complex endovascular aortic procedures. She is also interested in gender-based differences in the treatment and outcomes of vascular disease.

Dr. Christopher Owens' research is focused on exploring novel drugs or biologics designed to prevent vein graft failure and restenosis after angioplasty and stenting. He is pursuing a better understanding of the factors that modify vein graft remodeling to the arterial environment, and a better appreciation of adaptive physiology and healing kinetics. Dr. Owens hopes to gain insights into the temporal sequence of the physiological, biomechanical and biochemical challenges during veing graft healing. He is currently the PI of an NIH-funded research project studying endothelial function and vein graft remodeling.

Dr. Linda Reilly's research is focused on device and technique development and clinical trials of systems for endovascular repair of complex aortic aneurysms, particularly systems that allow application of the endovascular techniques to branch-bearing segments of the aorta (the aortic arch with the great vessels, the proximal abdominal aorta with the visceral and renal arteries and the iliac bifurcations with the hypogastric arteries). Her research also investigates the durability of endovascular repair of both complex and straight-forward aortic aneurysms.

Dr. Darren Schneider is the lead investigator on several clinical trials, including use of carotid artery stents for prevention of stroke, endovascular stent grafts for treatment of complex abdominal and thoracic aortic aneurysms, and stent grafts for treatment of lower extremity artery blockages. Dr. Schneider also directs an active laboratory research program focused on the development of stem cell therapy for the treatment of limb-threatening vascular disorders.